John Gordan

21PUBLICATIONS
132CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsCancer geneticsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Aug 14, 2026
A Phase II Trial of Pembrolizumab plus Granulocyte-Macrophage Colony-Stimulating Factor in Advanced Biliary Cancer.

|Mar 18, 2026
Clinical guideline for the diagnosis and treatment of fibrolamellar carcinoma.

Allison F O'Neill, Emily L Zeme, Ghassan K Abou-Alfa

|Dec 09, 2024
HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma.

Rigney E Turnham, Adriana Pitea, Gwendolyn M Jang

|Sep 26, 2024
DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming.

Ilaria Gritti, Jinkai Wan, Vajira Weeresekara

|Aug 05, 2024
Emerging Therapies for the Management of Human Epidermal Growth Factor Receptor 2-/ERBB2-Altered Advanced Biliary Tract Cancers.

Emily L Zeme, Katherine Van Loon, Robin K Kelley

|Apr 25, 2024
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update Clinical Insights.

Michal G Rose, Erin B Kennedy, Ghassan K Abou-Alfa

Pageof 4

Frequent Collaborators

6 joint publications

Robin Kate Kelley

4 joint publications

Ghassan K Abou-Alfa

4 joint publications

Danielle L Swaney

3 joint publications

Huat Chye Lim